These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 8777218)
1. Effect of prostaglandin E1 infusion on kidney function in patients with severe heart failure. Wutte M; Hülsmann M; Berger R; Siegel A; Stanek B; Pacher R J Heart Lung Transplant; 1996 Mar; 15(3):317-8. PubMed ID: 8777218 [No Abstract] [Full Text] [Related]
2. [Improved kidney function with intravenous prostaglandin E1 in patients with terminal heart failure]. Wutte M; Hülsmann M; Berger R; Rödler S; Frey B; Stanek B; Pacher R Wien Klin Wochenschr; 1998 Jul; 110(13-14):473-8. PubMed ID: 9746960 [TBL] [Abstract][Full Text] [Related]
3. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide. Kurien S; Warfield KT; Wood CM; Miller WL Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223 [TBL] [Abstract][Full Text] [Related]
5. Postoperative intravenous infusion of alprostadil (PGE1) does not improve renal function in hepatic transplant recipients. Manasia AR; Leibowitz AB; Miller CM; Silverstein JH; Schwartz M; Delgiudice R; Vallabhajosula S; Oropello JM; Benjamin E J Am Coll Surg; 1996 Apr; 182(4):347-52. PubMed ID: 8605558 [TBL] [Abstract][Full Text] [Related]
6. Acceptance of a pump-driven infusion therapy with prostaglandin E1 as a bridge to heart transplantation. Daneschvar H; Pacher R; Rödler S; Stanek B; Hülsmann M; Grimm M; Laufer G; Wolner E; Bunzel B Wien Klin Wochenschr; 1996; 108(16):510-4. PubMed ID: 8840497 [TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E1 infusion compared with prostacyclin infusion in patients with refractory heart failure: effects on hemodynamics and neurohumoral variables. Pacher R; Stanek B; Hülsmann M; Bojic A; Berger R; Frey B; Siegel A; Kos T; Ogris E; Grimm M; Laufer G J Heart Lung Transplant; 1997 Aug; 16(8):878-81. PubMed ID: 9286780 [TBL] [Abstract][Full Text] [Related]
8. [Effect of prostaglandin E1 on extravascular lung water in patients with severe heart failure]. Lenz K; Kranz A; Kramer L; Buder R; Schollmayer E Wien Klin Wochenschr; 1996; 108(16):505-9. PubMed ID: 8967094 [TBL] [Abstract][Full Text] [Related]
9. [The dobutamine-dopamine combination versus amrinone in congestive heart failure with a marked edematogenic sign complicated by functional kidney failure. A comparison between 2 different models of inotropic stimulation and diuresis potentiation]. De Vecchis R; Pucciarelli G; Nocerino L; Cocozza M; Setaro A; Torre G; Imperatore F Minerva Cardioangiol; 1998 May; 46(5):163-74. PubMed ID: 9842199 [TBL] [Abstract][Full Text] [Related]
10. Beneficial hemodynamic effects of prostaglandin E1 infusion in catecholamine-dependent heart failure: results of a prospective, randomized, controlled study. Pacher R; Globits S; Wutte M; Rödler S; Heinz G; Kreiner G; Radosztics S; Berger R; Presch I; Weber H Crit Care Med; 1994 Jul; 22(7):1084-90. PubMed ID: 8026195 [TBL] [Abstract][Full Text] [Related]
11. The effects of dobutamine on renal sympathetic activity in human heart failure. Al-Hesayen A; Parker JD J Cardiovasc Pharmacol; 2008 May; 51(5):434-6. PubMed ID: 18398381 [TBL] [Abstract][Full Text] [Related]
12. [Effects of intravenous nicardipine, prostaglandin E1, nitroglycerin, sodium nitroprusside, and epidural lidocaine on hepatic and renal blood flow during hypotensive anesthesia]. Tabo E; Yorozuya T; Shimizu I; Adachi N; Nagaro T; Arai T Masui; 2000 Dec; 49(12):1333-8. PubMed ID: 11193508 [TBL] [Abstract][Full Text] [Related]
13. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine. Wang DJ; Dowling TC; Meadows D; Ayala T; Marshall J; Minshall S; Greenberg N; Thattassery E; Fisher ML; Rao K; Gottlieb SS Circulation; 2004 Sep; 110(12):1620-5. PubMed ID: 15337695 [TBL] [Abstract][Full Text] [Related]
14. Lack of association between worsening renal function and mortality in heart failure patients treated with nesiritide. Miller WL; Kurien S; Warfield KT; Wood CM; Jaffe AS Int J Cardiol; 2008 May; 126(2):234-9. PubMed ID: 17482692 [TBL] [Abstract][Full Text] [Related]
15. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure. Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651 [TBL] [Abstract][Full Text] [Related]
16. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure. Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of prostaglandin E1 therapy for sudden deafness. Nakashima T; Kuno K; Yanagita N Laryngoscope; 1989 May; 99(5):542-6. PubMed ID: 2709943 [TBL] [Abstract][Full Text] [Related]
18. Hemodynamic and neurohumoral effects of long-term prostaglandin E1 infusions in outpatients with severe congestive heart failure. Hülsmann M; Stanek B; Frey B; Berger R; Rödler S; Siegel A; Hartter E; Schuller M; Ogris E; Pacher R J Heart Lung Transplant; 1997 May; 16(5):556-62. PubMed ID: 9171275 [TBL] [Abstract][Full Text] [Related]
19. VGAM induced high-flow congestive heart failure responsive to PGE1 infusion. Karam O; da Cruz E; Rimensberger PC Int J Cardiol; 2009 Feb; 132(2):e60-2. PubMed ID: 18022260 [TBL] [Abstract][Full Text] [Related]
20. Effect of prostaglandin E1 infusion in severe chronic heart failure. Pacher R; Stanek B; Hülsmann M; Sinzinger H Prostaglandins; 1997 Apr; 53(4):221-35. PubMed ID: 9167210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]